Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-1983 | |
| Operating Expenses | 173 |
| Operating Income | -173 |
| Other Income | 10 |
| Pre-tax Income | -163 |
| Net Income Continuous | -163 |
| Net Income | $-163 |
| EPS Basic Total Ops | -0.08 |
| EPS Basic Continuous Ops | -0.08 |
| EPS Diluted Total Ops | -0.08 |
| EPS Diluted Continuous Ops | -0.08 |
| EBITDA(a) | $-173 |